During this planning process, we invite you to make suggestions for the future of DAIDS clinical research. Provide your input using the link below and review information from previous meetings under "Slide Presentations and Meeting Summaries."

Opportunities for input

• Submit comments online - Please note: DAIDS is no longer accepting input on the Leadership Group RFA, due to its imminent release. Comments on the Site RFA are still welcome. 

• Final Presentation to ARAC upon approval (PDF)

Key Questions

1. Investing in Research
   What are the scientific priorities in HIV vaccine, prevention and therapeutic research in which DAIDS should focus its efforts?

2. Facilitating Integration
   What should the role of DAIDS be, if any, to facilitate the integration of vaccine, prevention and treatment research?

3. Collaboration with Investigators
   What should the role of DAIDS be, if any, in forging collaborations among researchers/research institutions?

4. Efficiency
   What can DAIDS do to improve the efficiency of its clinical research efforts?

5. Expanding Outreach
   What are the knowledge gaps, specific themes, content areas, and/or key audiences in which DAIDS should focus its outreach efforts?

   Background

   Beginning in October 2001, DAIDS has been reviewing and discussing the planning of the future DAIDS clinical research agenda, involving network leaders, members of the community, and others. All have agreed that the present structure has been effective but not necessarily efficient and is not well suited to meet future research challenges, particularly for international research. An alarming 96 percent of HIV/AIDS is occurring in developing countries, and in order to address global issues we will need to adjust many of our research plans. That said, important research questions remain that should be addressed domestically and there are still underserved populations in the U.S. in which the epidemic is rampant. As we move forward in restructuring the clinical research program, it must find a way to prioritize and balance these competing demands. All of the current research networks, namely AACTG, PACTG, CPCRA, HVTN, HPTN, and ESPRIT, will be recompeted in 2006.

Slide Presentations and Meeting Summaries

• AIDS Research Advisory Committee (ARAC)
  Information presented at ARAC meetings regarding the recompetition and the research plan

• Consultations
  Network meeting summaries, notes, attendance, and reports

• Current DAIDS Clinical Research Networks
  Official Websites

Disclaimer